| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 MMP20 UQCRC2 ADAMTS14 MMP11 MMP17 | 1.52e-08 | 120 | 106 | 9 | GO:0004222 |
| GeneOntologyMolecularFunction | metallopeptidase activity | ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 MMP20 UQCRC2 ADAMTS14 MMP11 MMP17 | 1.20e-06 | 200 | 106 | 9 | GO:0008237 |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 2.79e-05 | 2 | 106 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | natriuretic peptide receptor activity | 8.35e-05 | 3 | 106 | 2 | GO:0016941 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 NCSTN MMP20 UQCRC2 ADAMTS14 MMP11 MMP17 | 9.76e-05 | 430 | 106 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | lyase activity | 1.38e-04 | 212 | 106 | 7 | GO:0016829 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.55e-04 | 20 | 106 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.66e-04 | 4 | 106 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.65e-04 | 107 | 106 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | ligase activity | 3.34e-04 | 174 | 106 | 6 | GO:0016874 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 4.13e-04 | 6 | 106 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.13e-04 | 6 | 106 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | biotin binding | 4.13e-04 | 6 | 106 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | organic acid binding | 4.15e-04 | 254 | 106 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 4.32e-04 | 28 | 106 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ADCY10 CYP1B1 CAD ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 MARCHF6 ZMYM2 FBXO11 SLC39A4 MMP20 ALKBH1 HERC2 MMP11 MMP17 | 5.23e-04 | 1189 | 106 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 5.76e-04 | 7 | 106 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 7.66e-04 | 8 | 106 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 8.41e-04 | 35 | 106 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | zinc ion binding | CAD ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 MARCHF6 ZMYM2 FBXO11 SLC39A4 MMP20 HERC2 MMP11 MMP17 | 8.73e-04 | 891 | 106 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | amide binding | 1.08e-03 | 299 | 106 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.22e-03 | 10 | 106 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | frizzled binding | 1.44e-03 | 42 | 106 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.74e-03 | 239 | 106 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 2.10e-03 | 13 | 106 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.11e-03 | 48 | 106 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.24e-03 | 49 | 106 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | peptidase activity | ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 NCSTN MMP20 UQCRC2 ADAMTS14 MMP11 MMP17 | 2.51e-03 | 654 | 106 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 3.19e-03 | 16 | 106 | 2 | GO:0016812 | |
| GeneOntologyMolecularFunction | floppase activity | 3.19e-03 | 16 | 106 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.04e-03 | 18 | 106 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 4.04e-03 | 18 | 106 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 4.98e-03 | 20 | 106 | 2 | GO:0046624 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 2.54e-07 | 53 | 103 | 6 | GO:0030574 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 7.77e-07 | 148 | 103 | 8 | GO:0032963 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | CYP1B1 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 ITGA2 MMP20 WNT3A ADAMTS14 MMP11 MMP17 | 2.92e-06 | 377 | 103 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | CYP1B1 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 ITGA2 MMP20 WNT3A ADAMTS14 MMP11 MMP17 | 2.99e-06 | 378 | 103 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | CYP1B1 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 ITGA2 MMP20 WNT3A ADAMTS14 MMP11 MMP17 | 3.07e-06 | 379 | 103 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 6.65e-06 | 8 | 103 | 3 | GO:2000427 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 1.41e-05 | 10 | 103 | 3 | GO:2000425 | |
| GeneOntologyBiologicalProcess | positive regulation of collateral sprouting in absence of injury | 2.47e-05 | 2 | 103 | 2 | GO:0048697 | |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 2.47e-05 | 2 | 103 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.93e-05 | 76 | 103 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 4.91e-05 | 421 | 103 | 10 | GO:0044282 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CYP1B1 CAD ACACA ACACB GAPDH UGT1A5 BDH2 DDO UGT1A4 UGT1A3 OXSM GATD1 HAL CARNS1 HMGCLL1 ADIPOR2 | 5.29e-05 | 1035 | 103 | 16 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP1B1 CAD ACACA ACACB GAPDH UGT1A5 BDH2 DDO UGT1A4 UGT1A3 OXSM GATD1 HAL CARNS1 HMGCLL1 ADIPOR2 | 6.86e-05 | 1058 | 103 | 16 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP1B1 CAD ACACA ACACB GAPDH UGT1A5 BDH2 DDO UGT1A4 UGT1A3 OXSM GATD1 HAL CARNS1 HMGCLL1 ADIPOR2 | 7.33e-05 | 1064 | 103 | 16 | GO:0006082 |
| GeneOntologyBiologicalProcess | regulation of collateral sprouting in absence of injury | 7.38e-05 | 3 | 103 | 2 | GO:0048696 | |
| GeneOntologyBiologicalProcess | response to cortisol | 1.47e-04 | 4 | 103 | 2 | GO:0051414 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.51e-04 | 21 | 103 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.51e-04 | 21 | 103 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | collateral sprouting in absence of injury | 2.45e-04 | 5 | 103 | 2 | GO:0048669 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP1B1 ACACA ACACB GAPDH UGT1A5 BDH2 UGT1A4 UGT1A3 OXSM GATD1 HAL ADIPOR2 | 2.87e-04 | 731 | 103 | 12 | GO:0032787 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.89e-04 | 26 | 103 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.89e-04 | 26 | 103 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | malonyl-CoA metabolic process | 3.66e-04 | 6 | 103 | 2 | GO:2001293 | |
| GeneOntologyCellularComponent | extracellular matrix | COL6A2 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 WNT3 LAMA3 MMP20 WNT5B COCH ADAMTS14 MMP11 MMP17 | 2.51e-05 | 656 | 105 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL6A2 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 WNT3 LAMA3 MMP20 WNT5B COCH ADAMTS14 MMP11 MMP17 | 2.59e-05 | 658 | 105 | 13 | GO:0030312 |
| Domain | - | 1.88e-08 | 81 | 106 | 8 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 1.88e-08 | 81 | 106 | 8 | IPR024079 | |
| Domain | ZINC_PROTEASE | 8.50e-08 | 98 | 106 | 8 | PS00142 | |
| Domain | ADAM_spacer1 | 1.66e-07 | 23 | 106 | 5 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.66e-07 | 23 | 106 | 5 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.09e-07 | 24 | 106 | 5 | IPR013273 | |
| Domain | ATP_GRASP | 9.39e-07 | 14 | 106 | 4 | PS50975 | |
| Domain | ATP-grasp | 9.39e-07 | 14 | 106 | 4 | IPR011761 | |
| Domain | CPSASE_1 | 1.76e-06 | 5 | 106 | 3 | PS00866 | |
| Domain | Pep_M12B_propep | 2.64e-06 | 39 | 106 | 5 | PF01562 | |
| Domain | Peptidase_M12B_N | 2.64e-06 | 39 | 106 | 5 | IPR002870 | |
| Domain | - | 2.82e-06 | 18 | 106 | 4 | 3.30.470.20 | |
| Domain | DISINTEGRIN_1 | 3.01e-06 | 40 | 106 | 5 | PS00427 | |
| Domain | Reprolysin | 3.01e-06 | 40 | 106 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 3.01e-06 | 40 | 106 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.01e-06 | 40 | 106 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 3.01e-06 | 40 | 106 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 3.41e-06 | 41 | 106 | 5 | IPR001762 | |
| Domain | CPSASE_2 | 3.51e-06 | 6 | 106 | 3 | PS00867 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 6.12e-06 | 7 | 106 | 3 | IPR005479 | |
| Domain | BC-like_N | 6.12e-06 | 7 | 106 | 3 | IPR005481 | |
| Domain | CPSase_L_D2 | 6.12e-06 | 7 | 106 | 3 | PF02786 | |
| Domain | Biotin_carb_N | 6.12e-06 | 7 | 106 | 3 | PF00289 | |
| Domain | ATP_grasp_subdomain_2 | 2.74e-05 | 31 | 106 | 4 | IPR013816 | |
| Domain | TSP_1 | 2.90e-05 | 63 | 106 | 5 | PF00090 | |
| Domain | Wnt3 | 3.19e-05 | 2 | 106 | 2 | IPR009141 | |
| Domain | ACC_central | 3.19e-05 | 2 | 106 | 2 | PF08326 | |
| Domain | AcCoA_COase_cen | 3.19e-05 | 2 | 106 | 2 | IPR013537 | |
| Domain | TSP1 | 3.37e-05 | 65 | 106 | 5 | SM00209 | |
| Domain | TSP1_rpt | 3.37e-05 | 65 | 106 | 5 | IPR000884 | |
| Domain | TSP1 | 3.37e-05 | 65 | 106 | 5 | PS50092 | |
| Domain | - | 4.88e-05 | 13 | 106 | 3 | 3.40.50.20 | |
| Domain | PreATP-grasp_dom | 6.18e-05 | 14 | 106 | 3 | IPR016185 | |
| Domain | - | 7.69e-05 | 15 | 106 | 3 | 3.30.1490.20 | |
| Domain | CYSTEINE_SWITCH | 8.44e-05 | 41 | 106 | 4 | PS00546 | |
| Domain | Ryanodine_rcpt | 9.54e-05 | 3 | 106 | 2 | IPR003032 | |
| Domain | ANF_RECEPTORS | 9.54e-05 | 3 | 106 | 2 | PS00458 | |
| Domain | Ryanrecept_TM4-6 | 9.54e-05 | 3 | 106 | 2 | IPR009460 | |
| Domain | RyR | 9.54e-05 | 3 | 106 | 2 | PF02026 | |
| Domain | ANPR/GUC | 9.54e-05 | 3 | 106 | 2 | IPR001170 | |
| Domain | RR_TM4-6 | 9.54e-05 | 3 | 106 | 2 | PF06459 | |
| Domain | Ryan_recept | 9.54e-05 | 3 | 106 | 2 | IPR013333 | |
| Domain | Pept_M10_metallopeptidase | 1.02e-04 | 43 | 106 | 4 | IPR001818 | |
| Domain | ATP_grasp_subdomain_1 | 1.36e-04 | 18 | 106 | 3 | IPR013815 | |
| Domain | Pept_M10A_stromelysin-type | 1.36e-04 | 18 | 106 | 3 | IPR016293 | |
| Domain | Wnt | 1.61e-04 | 19 | 106 | 3 | IPR005817 | |
| Domain | WNT1 | 1.61e-04 | 19 | 106 | 3 | PS00246 | |
| Domain | PLAC | 1.61e-04 | 19 | 106 | 3 | PS50900 | |
| Domain | Wnt_CS | 1.61e-04 | 19 | 106 | 3 | IPR018161 | |
| Domain | wnt | 1.61e-04 | 19 | 106 | 3 | PF00110 | |
| Domain | PLAC | 1.61e-04 | 19 | 106 | 3 | IPR010909 | |
| Domain | WNT1 | 1.61e-04 | 19 | 106 | 3 | SM00097 | |
| Domain | Carboxyl_trans | 1.90e-04 | 4 | 106 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 1.90e-04 | 4 | 106 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 1.90e-04 | 4 | 106 | 2 | PS50980 | |
| Domain | COA_CT_N | 1.90e-04 | 4 | 106 | 2 | IPR011762 | |
| Domain | COA_CT_C | 1.90e-04 | 4 | 106 | 2 | IPR011763 | |
| Domain | Carboxyl_trans | 1.90e-04 | 4 | 106 | 2 | IPR000022 | |
| Domain | UDPGT | 2.19e-04 | 21 | 106 | 3 | PF00201 | |
| Domain | UDPGT | 2.19e-04 | 21 | 106 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 2.19e-04 | 21 | 106 | 3 | IPR002213 | |
| Domain | Hemopexin-like_dom | 2.90e-04 | 23 | 106 | 3 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 2.90e-04 | 23 | 106 | 3 | IPR018487 | |
| Domain | HEMOPEXIN | 2.90e-04 | 23 | 106 | 3 | PS00024 | |
| Domain | - | 2.90e-04 | 23 | 106 | 3 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.90e-04 | 23 | 106 | 3 | PS51642 | |
| Domain | HX | 2.90e-04 | 23 | 106 | 3 | SM00120 | |
| Domain | M10A_MMP | 2.90e-04 | 23 | 106 | 3 | IPR033739 | |
| Domain | Hemopexin | 2.90e-04 | 23 | 106 | 3 | PF00045 | |
| Domain | Pept_M10A | 2.90e-04 | 23 | 106 | 3 | IPR021190 | |
| Domain | Biotin_BS | 3.16e-04 | 5 | 106 | 2 | IPR001882 | |
| Domain | Anaphylatoxin_comp_syst | 3.16e-04 | 5 | 106 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.16e-04 | 5 | 106 | 2 | IPR001840 | |
| Domain | Biotin_COase_C | 3.16e-04 | 5 | 106 | 2 | IPR005482 | |
| Domain | BC | 3.16e-04 | 5 | 106 | 2 | PS50979 | |
| Domain | Biotin_carb_C | 3.16e-04 | 5 | 106 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 3.16e-04 | 5 | 106 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 3.16e-04 | 5 | 106 | 2 | IPR011764 | |
| Domain | BIOTIN | 3.16e-04 | 5 | 106 | 2 | PS00188 | |
| Domain | Peptidase_M10 | 3.30e-04 | 24 | 106 | 3 | PF00413 | |
| Domain | ADAM_Cys-rich | 4.71e-04 | 27 | 106 | 3 | IPR006586 | |
| Domain | ACR | 4.71e-04 | 27 | 106 | 3 | SM00608 | |
| Domain | RIH_assoc-dom | 4.72e-04 | 6 | 106 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 4.72e-04 | 6 | 106 | 2 | PF08709 | |
| Domain | Rudment_hybrid_motif | 4.72e-04 | 6 | 106 | 2 | IPR011054 | |
| Domain | RIH_assoc | 4.72e-04 | 6 | 106 | 2 | PF08454 | |
| Domain | RIH_dom | 4.72e-04 | 6 | 106 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.72e-04 | 6 | 106 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.72e-04 | 6 | 106 | 2 | IPR015925 | |
| Domain | - | 4.72e-04 | 6 | 106 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.72e-04 | 6 | 106 | 2 | PF01365 | |
| Domain | Peptidase_Metallo | 5.83e-04 | 29 | 106 | 3 | IPR006026 | |
| Domain | ZnMc | 5.83e-04 | 29 | 106 | 3 | SM00235 | |
| Domain | ANATO | 6.58e-04 | 7 | 106 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 6.58e-04 | 7 | 106 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.58e-04 | 7 | 106 | 2 | PS01177 | |
| Domain | ANATO | 6.58e-04 | 7 | 106 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 6.58e-04 | 7 | 106 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 8.74e-04 | 8 | 106 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 8.74e-04 | 8 | 106 | 2 | PF10569 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A2 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 LAMA3 NCSTN ITGA2 MMP20 ADAMTS14 MMP11 MMP17 | 1.52e-07 | 300 | 82 | 12 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.49e-06 | 140 | 82 | 8 | M587 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.90e-06 | 39 | 82 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.90e-06 | 39 | 82 | 5 | MM15165 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.23e-05 | 25 | 82 | 4 | M605 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.36e-05 | 90 | 82 | 6 | M631 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | CYP1B1 ACACA ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 UGT1A4 ADAMTS14 OPLAH | 1.43e-05 | 250 | 82 | 9 | M27554 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A2 ADAMTS4 ADAMTS3 ADAMTS2 ITGA2 MMP20 ADAMTS14 MMP11 MMP17 | 1.83e-05 | 258 | 82 | 9 | MM14572 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.03e-05 | 11 | 82 | 3 | M47958 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.04e-05 | 109 | 82 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.48e-05 | 111 | 82 | 6 | M27416 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.61e-05 | 68 | 82 | 5 | M27303 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.87e-05 | 76 | 82 | 5 | MM14573 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 8.21e-05 | 15 | 82 | 3 | MM15697 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 1.72e-04 | 19 | 82 | 3 | M47836 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.01e-04 | 20 | 82 | 3 | MM14721 | |
| Pathway | WP_ESTROGEN_METABOLISM | 2.70e-04 | 22 | 82 | 3 | MM15888 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.89e-04 | 55 | 82 | 4 | M14933 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.09e-04 | 23 | 82 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.52e-04 | 24 | 82 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.98e-04 | 25 | 82 | 3 | M17787 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 3.98e-04 | 25 | 82 | 3 | MM14940 | |
| Pathway | WP_GLUCURONIDATION | 3.98e-04 | 25 | 82 | 3 | MM15820 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.31e-04 | 61 | 82 | 4 | MM14637 | |
| Pathway | WP_GLUCURONIDATION | 4.48e-04 | 26 | 82 | 3 | M39404 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 4.48e-04 | 26 | 82 | 3 | M27239 | |
| Pathway | WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY | 4.94e-04 | 6 | 82 | 2 | M40043 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.26e-04 | 114 | 82 | 5 | MM14571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 5.60e-04 | 28 | 82 | 3 | M47835 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 5.60e-04 | 28 | 82 | 3 | M19580 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 5.70e-04 | 116 | 82 | 5 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 5.93e-04 | 117 | 82 | 5 | M39530 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.17e-04 | 67 | 82 | 4 | M26999 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 6.21e-04 | 29 | 82 | 3 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 6.21e-04 | 29 | 82 | 3 | M47377 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 6.21e-04 | 29 | 82 | 3 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 6.88e-04 | 30 | 82 | 3 | M39652 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 6.89e-04 | 7 | 82 | 2 | MM14685 | |
| Pathway | REACTOME_HISTIDINE_CATABOLISM | 6.89e-04 | 7 | 82 | 2 | MM15398 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.28e-04 | 70 | 82 | 4 | M16794 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 8.02e-04 | 261 | 82 | 7 | M42565 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 8.33e-04 | 32 | 82 | 3 | MM14719 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 9.13e-04 | 33 | 82 | 3 | M4086 | |
| Pathway | REACTOME_SYNTHESIS_OF_KETONE_BODIES | 9.15e-04 | 8 | 82 | 2 | M27718 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 9.15e-04 | 8 | 82 | 2 | M47872 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 9.15e-04 | 8 | 82 | 2 | MM15106 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 9.15e-04 | 8 | 82 | 2 | M26991 | |
| Pathway | REACTOME_HISTIDINE_CATABOLISM | 9.15e-04 | 8 | 82 | 2 | M27678 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 9.15e-04 | 8 | 82 | 2 | M27031 | |
| Pathway | REACTOME_SYNTHESIS_OF_KETONE_BODIES | 9.15e-04 | 8 | 82 | 2 | MM15460 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 9.97e-04 | 34 | 82 | 3 | M27461 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 1.17e-03 | 9 | 82 | 2 | M40064 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.18e-03 | 36 | 82 | 3 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.28e-03 | 37 | 82 | 3 | M47411 | |
| Pathway | WP_LEPTIN_AND_ADIPONECTIN | 1.46e-03 | 10 | 82 | 2 | M39539 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 1.46e-03 | 10 | 82 | 2 | M27361 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 1.46e-03 | 10 | 82 | 2 | MM15437 | |
| Pathway | WP_LEPTIN_AND_ADIPONECTIN | 1.46e-03 | 10 | 82 | 2 | MM15824 | |
| Pathway | REACTOME_KETONE_BODY_METABOLISM | 1.46e-03 | 10 | 82 | 2 | M27706 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.46e-03 | 143 | 82 | 5 | M27275 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 1.57e-03 | 86 | 82 | 4 | M39375 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 1.60e-03 | 40 | 82 | 3 | M7934 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.72e-03 | 41 | 82 | 3 | M7399 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.78e-03 | 11 | 82 | 2 | M47874 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 1.78e-03 | 11 | 82 | 2 | MM15101 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.78e-03 | 11 | 82 | 2 | MM1430 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 1.78e-03 | 11 | 82 | 2 | M27086 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 1.78e-03 | 11 | 82 | 2 | MM14764 | |
| Pathway | WNT_SIGNALING | 1.78e-03 | 89 | 82 | 4 | M5493 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 1.94e-03 | 91 | 82 | 4 | M39570 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.12e-03 | 44 | 82 | 3 | M45014 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 2.12e-03 | 44 | 82 | 3 | MM15878 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.12e-03 | 12 | 82 | 2 | MM1368 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.26e-03 | 45 | 82 | 3 | M47412 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.26e-03 | 45 | 82 | 3 | MM15694 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 2.40e-03 | 46 | 82 | 3 | M47409 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 2.40e-03 | 46 | 82 | 3 | M46450 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 2.50e-03 | 13 | 82 | 2 | M39589 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.50e-03 | 13 | 82 | 2 | M4732 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 2.54e-03 | 98 | 82 | 4 | MM15942 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 2.80e-03 | 166 | 82 | 5 | M16024 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.81e-03 | 325 | 82 | 7 | M12868 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 2.86e-03 | 326 | 82 | 7 | M39379 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 2.91e-03 | 14 | 82 | 2 | M27098 | |
| Pathway | REACTOME_CARNITINE_METABOLISM | 2.91e-03 | 14 | 82 | 2 | MM14788 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.23e-03 | 51 | 82 | 3 | M17726 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 3.34e-03 | 15 | 82 | 2 | M832 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.34e-03 | 15 | 82 | 2 | M7146 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.41e-03 | 52 | 82 | 3 | M14171 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.49e-03 | 107 | 82 | 4 | MM14595 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.60e-03 | 108 | 82 | 4 | M17034 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.60e-03 | 53 | 82 | 3 | MM14566 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.72e-03 | 109 | 82 | 4 | M18788 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 4.00e-03 | 55 | 82 | 3 | M17807 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 4.21e-03 | 56 | 82 | 3 | M1053 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 4.30e-03 | 17 | 82 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 4.30e-03 | 17 | 82 | 2 | MM1369 | |
| Pubmed | ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. | 8.47e-11 | 4 | 107 | 4 | 10094461 | |
| Pubmed | 4.22e-10 | 5 | 107 | 4 | 11831030 | ||
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 7.35e-10 | 15 | 107 | 5 | 38871984 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 11741898 | ||
| Pubmed | The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. | 2.83e-08 | 3 | 107 | 3 | 25863161 | |
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 22205175 | ||
| Pubmed | 1.25e-07 | 75 | 107 | 6 | 20637190 | ||
| Pubmed | 1.50e-07 | 16 | 107 | 4 | 30579834 | ||
| Pubmed | 1.95e-07 | 17 | 107 | 4 | 10464288 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 16556917 | ||
| Pubmed | 8.58e-07 | 24 | 107 | 4 | 29791855 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 9.25e-07 | 57 | 107 | 5 | 21886157 | |
| Pubmed | 2.35e-06 | 9 | 107 | 3 | 22511988 | ||
| Pubmed | 2.35e-06 | 9 | 107 | 3 | 1339448 | ||
| Pubmed | 3.01e-06 | 383 | 107 | 9 | 29331416 | ||
| Pubmed | 3.34e-06 | 10 | 107 | 3 | 23642732 | ||
| Pubmed | Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. | 3.34e-06 | 10 | 107 | 3 | 8275860 | |
| Pubmed | 3.34e-06 | 10 | 107 | 3 | 11465080 | ||
| Pubmed | 3.34e-06 | 10 | 107 | 3 | 23371916 | ||
| Pubmed | 3.34e-06 | 10 | 107 | 3 | 11167130 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.34e-06 | 10 | 107 | 3 | 22558097 | |
| Pubmed | The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family. | 3.34e-06 | 10 | 107 | 3 | 10866835 | |
| Pubmed | Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. | 6.10e-06 | 12 | 107 | 3 | 32648916 | |
| Pubmed | 6.10e-06 | 12 | 107 | 3 | 19419973 | ||
| Pubmed | 6.10e-06 | 12 | 107 | 3 | 15778975 | ||
| Pubmed | 6.10e-06 | 12 | 107 | 3 | 19690384 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 6.10e-06 | 12 | 107 | 3 | 25770910 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 6.10e-06 | 12 | 107 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.92e-06 | 13 | 107 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.92e-06 | 13 | 107 | 3 | 25246029 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | CYP1B1 COL6A2 ACACA GAPDH ADAMTS1 PDGFRB ARID1A CBL ODR4 MTIF2 SLC39A6 OXSM UQCRC2 HAL ADAMTS14 MMP11 | 9.37e-06 | 1451 | 107 | 16 | 30550785 |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 9.38e-06 | 2 | 107 | 2 | 16565498 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15998580 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 9.38e-06 | 2 | 107 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 9.38e-06 | 2 | 107 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 9.38e-06 | 2 | 107 | 2 | 17645767 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8068691 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12207352 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11556325 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 9.38e-06 | 2 | 107 | 2 | 27758680 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 9.38e-06 | 2 | 107 | 2 | 23749435 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23918728 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24944901 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 9.38e-06 | 2 | 107 | 2 | 3037333 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15796911 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11726230 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 4216347 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24641623 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 9.38e-06 | 2 | 107 | 2 | 6950384 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 9.38e-06 | 2 | 107 | 2 | 8428773 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 9.38e-06 | 2 | 107 | 2 | 21345967 | |
| Pubmed | Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. | 9.38e-06 | 2 | 107 | 2 | 20139635 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28081256 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2572548 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2302180 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26976583 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 9.38e-06 | 2 | 107 | 2 | 18091514 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29080553 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8898078 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 9.38e-06 | 2 | 107 | 2 | 25339671 | |
| Pubmed | Regulation of WNT3 and WNT3A mRNAs in human cancer cell lines NT2, MCF-7, and MKN45. | 9.38e-06 | 2 | 107 | 2 | 11788904 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17728371 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6149580 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6149581 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12115608 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3542363 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2387317 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 14550562 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16908004 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 7365238 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 7391573 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 9.38e-06 | 2 | 107 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 9.38e-06 | 2 | 107 | 2 | 17971229 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 6881182 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2001840 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 9.38e-06 | 2 | 107 | 2 | 17921792 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 9.38e-06 | 2 | 107 | 2 | 6978711 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25001074 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 35898513 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28873507 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 9.38e-06 | 2 | 107 | 2 | 6832377 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3794341 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 10677481 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24338821 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22785613 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 9.38e-06 | 2 | 107 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 9.38e-06 | 2 | 107 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 9.38e-06 | 2 | 107 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 9.38e-06 | 2 | 107 | 2 | 3696167 | |
| Cytoband | 2q37 | 5.28e-05 | 31 | 107 | 3 | 2q37 | |
| Cytoband | 8q24.3 | 1.48e-04 | 113 | 107 | 4 | 8q24.3 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.66e-08 | 19 | 80 | 5 | 50 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 5.78e-05 | 3 | 80 | 2 | 287 | |
| GeneFamily | Wnt family|Endogenous ligands | 7.68e-05 | 19 | 80 | 3 | 360 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 1.58e-04 | 24 | 80 | 3 | 891 | |
| GeneFamily | UDP glucuronosyltransferases | 3.77e-04 | 32 | 80 | 3 | 363 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.82e-04 | 9 | 80 | 2 | 1234 | |
| GeneFamily | Ankyrin repeat domain containing | 4.39e-03 | 242 | 80 | 5 | 403 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 5.43e-03 | 25 | 80 | 2 | 504 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP | 1.71e-06 | 200 | 107 | 8 | M8836 | |
| Coexpression | NABA_ECM_REGULATORS | 6.18e-06 | 238 | 107 | 8 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 6.98e-06 | 242 | 107 | 8 | MM17062 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.42e-05 | 75 | 107 | 5 | MM1143 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 1.86e-05 | 200 | 107 | 7 | M6480 | |
| Coexpression | KRAS.PROSTATE_UP.V1_UP | 2.14e-05 | 137 | 107 | 6 | M2902 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 5.85e-05 | 421 | 107 | 9 | MM985 | |
| Coexpression | NABA_MATRISOME | COL6A2 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 WNT3 LAMA3 MMP20 WNT5B COCH WNT3A ADAMTS14 MMP11 MMP17 | 6.18e-05 | 1008 | 107 | 14 | MM17056 |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 7.17e-05 | 20 | 107 | 3 | M48357 | |
| Coexpression | NABA_MATRISOME | COL6A2 ADAMTS4 ADAMTS3 ADAMTS2 ADAMTS1 WNT3 LAMA3 MMP20 WNT5B COCH WNT3A ADAMTS14 MMP11 MMP17 | 7.46e-05 | 1026 | 107 | 14 | M5889 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | COL6A2 ADAMTS2 ADAMTS1 PDGFRB ITGA2 RYR2 GALNT17 HMGCLL1 TBX2 | 1.11e-09 | 195 | 107 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.25e-08 | 193 | 107 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-08 | 198 | 107 | 8 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.12e-07 | 158 | 107 | 7 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-07 | 185 | 107 | 7 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 3.65e-07 | 188 | 107 | 7 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 3.65e-07 | 188 | 107 | 7 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-07 | 189 | 107 | 7 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.06e-07 | 191 | 107 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.20e-07 | 192 | 107 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 4.66e-07 | 195 | 107 | 7 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-07 | 195 | 107 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.66e-07 | 195 | 107 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-07 | 197 | 107 | 7 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-07 | 197 | 107 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-07 | 198 | 107 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.17e-07 | 198 | 107 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.35e-07 | 199 | 107 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 200 | 107 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.53e-07 | 200 | 107 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.53e-07 | 200 | 107 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 5.53e-07 | 200 | 107 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.53e-07 | 200 | 107 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.28e-06 | 168 | 107 | 6 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_F|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.51e-06 | 170 | 107 | 6 | 71718dcebd48105994c313bb55babc70301170a0 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.63e-06 | 171 | 107 | 6 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.88e-06 | 173 | 107 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.15e-06 | 175 | 107 | 6 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.15e-06 | 175 | 107 | 6 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-06 | 181 | 107 | 6 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.53e-06 | 184 | 107 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 5.71e-06 | 185 | 107 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.89e-06 | 186 | 107 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 5.89e-06 | 186 | 107 | 6 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.07e-06 | 187 | 107 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 189 | 107 | 6 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-06 | 190 | 107 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.65e-06 | 190 | 107 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.85e-06 | 191 | 107 | 6 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.85e-06 | 191 | 107 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.85e-06 | 191 | 107 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.06e-06 | 192 | 107 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.06e-06 | 192 | 107 | 6 | 859a32c9e4ed6961897b2ccaecde73a599471df9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.06e-06 | 192 | 107 | 6 | 89e1da82fa2069dac7adb9cba3e8b6c0179e0dc5 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-06 | 192 | 107 | 6 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-06 | 192 | 107 | 6 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.06e-06 | 192 | 107 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 193 | 107 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.27e-06 | 193 | 107 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | ac088c8f27b5b1888610e461ff45870ca60da886 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.27e-06 | 193 | 107 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 193 | 107 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-06 | 194 | 107 | 6 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.49e-06 | 194 | 107 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 7.49e-06 | 194 | 107 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.49e-06 | 194 | 107 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 7.49e-06 | 194 | 107 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 7.49e-06 | 194 | 107 | 6 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 7.94e-06 | 196 | 107 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 196 | 107 | 6 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 196 | 107 | 6 | 46d665de09f8164690b9a3e0acf0b0afa3f81b3d | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.94e-06 | 196 | 107 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 7.94e-06 | 196 | 107 | 6 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 196 | 107 | 6 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.94e-06 | 196 | 107 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.17e-06 | 197 | 107 | 6 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.17e-06 | 197 | 107 | 6 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 197 | 107 | 6 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 197 | 107 | 6 | d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-06 | 198 | 107 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 8.41e-06 | 198 | 107 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.41e-06 | 198 | 107 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.41e-06 | 198 | 107 | 6 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-06 | 198 | 107 | 6 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-06 | 198 | 107 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-06 | 199 | 107 | 6 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-06 | 199 | 107 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-06 | 199 | 107 | 6 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-06 | 199 | 107 | 6 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-06 | 199 | 107 | 6 | c972d3036151403f26fa9d6271520639c281ab84 | |
| Drug | chondroitin sulfate | COL6A2 ADAMTS4 ADAMTS3 ADAMTS1 PDGFRB UGT1A5 LAMA3 UGT1A4 UGT1A3 NUDT6 ERAS C4A MMP17 | 7.39e-08 | 413 | 107 | 13 | CID000024766 |
| Drug | PCB-61 | 4.45e-07 | 14 | 107 | 4 | CID000036401 | |
| Drug | 6-methylsalicylic acid | 4.46e-07 | 33 | 107 | 5 | CID000011279 | |
| Drug | AC1L4NWK | 6.05e-07 | 15 | 107 | 4 | CID000189017 | |
| Drug | AC1L9MYN | 1.34e-06 | 18 | 107 | 4 | CID000449297 | |
| Drug | Br 2 | 1.34e-06 | 18 | 107 | 4 | CID003060900 | |
| Drug | AC1L1DD6 | 2.10e-06 | 179 | 107 | 8 | CID000002299 | |
| Drug | quercetin | CYP1B1 COL6A2 NPR2 PDGFRB UGT1A5 MARCHF6 LAMA3 MMP20 UGT1A4 UGT1A3 MMP11 MMP17 | 2.84e-06 | 482 | 107 | 12 | CID005280343 |
| Drug | salicylamide | 3.04e-06 | 48 | 107 | 5 | CID000005147 | |
| Drug | coenzyme 1 | NPR2 NPR3 GAPDH BDH2 DDO NCSTN RYR2 RYR3 NUDT6 UQCRC2 HAL HMGCLL1 ALDH7A1 | 4.54e-06 | 596 | 107 | 13 | CID000000925 |
| Drug | imidazolone | 4.56e-06 | 24 | 107 | 4 | CID000000504 | |
| Drug | Invader | 6.59e-06 | 56 | 107 | 5 | CID006442259 | |
| Drug | DiMeIQx | 7.44e-06 | 27 | 107 | 4 | CID000104739 | |
| Drug | AC1MRQNQ | 8.30e-06 | 9 | 107 | 3 | CID003522271 | |
| Drug | DHPASiU | 8.30e-06 | 9 | 107 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 8.30e-06 | 9 | 107 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 8.30e-06 | 9 | 107 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 8.30e-06 | 9 | 107 | 3 | CID005460873 | |
| Drug | hydride | CACNA1E CYP1B1 APPBP2 NPR2 NPR3 CAD GAPDH ITGA2 PA2G4 C4A OXSM UQCRC2 HAL HMGCLL1 ALDH7A1 | 8.39e-06 | 835 | 107 | 15 | CID000000783 |
| Drug | CARMINE | 8.65e-06 | 28 | 107 | 4 | CID000014749 | |
| Drug | erucin | 8.65e-06 | 28 | 107 | 4 | CID000078160 | |
| Drug | AC1L9E0Q | 1.15e-05 | 30 | 107 | 4 | CID000443095 | |
| Drug | 4-ethylphenol | 1.32e-05 | 31 | 107 | 4 | CID000031242 | |
| Drug | Muracein C | 1.50e-05 | 32 | 107 | 4 | CID003086323 | |
| Drug | 4-nitrophenyl)imidazole | 1.62e-05 | 11 | 107 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 1.62e-05 | 11 | 107 | 3 | CID006442661 | |
| Drug | R(-)-Denopamine | 1.70e-05 | 33 | 107 | 4 | CID000003818 | |
| Drug | belinostat | CYP1B1 NPR3 CAD ACACB ADAMTS3 ITGA2 WNT5B GALNT17 COCH KIAA1549L PA2G4 WNT3A OPLAH | 1.79e-05 | 678 | 107 | 13 | ctd:C487081 |
| Drug | lamotrigine | 1.83e-05 | 116 | 107 | 6 | CID000003878 | |
| Drug | AC1NBU2S | 1.92e-05 | 117 | 107 | 6 | CID004473765 | |
| Drug | hydroxylamine | 2.03e-05 | 244 | 107 | 8 | CID000000787 | |
| Drug | N-OH-DABZ | 2.15e-05 | 12 | 107 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.15e-05 | 12 | 107 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 2.15e-05 | 12 | 107 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 2.15e-05 | 12 | 107 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.15e-05 | 12 | 107 | 3 | CID000276709 | |
| Drug | 1-butyne | 2.19e-05 | 2 | 107 | 2 | CID000007846 | |
| Drug | biotin p-nitrophenyl ester | 2.19e-05 | 2 | 107 | 2 | CID000083848 | |
| Drug | afloqualone | 2.19e-05 | 2 | 107 | 2 | ctd:C033541 | |
| Drug | AC1L9DGV | 2.42e-05 | 36 | 107 | 4 | CID000417381 | |
| Drug | 2,2,2-trichloroethanol | 2.43e-05 | 73 | 107 | 5 | CID000008259 | |
| Drug | AC1L1GXT | 2.60e-05 | 74 | 107 | 5 | CID000003890 | |
| Drug | tritanol | 2.79e-05 | 13 | 107 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 2.79e-05 | 13 | 107 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 2.79e-05 | 13 | 107 | 3 | CID000000411 | |
| Drug | ammonia | CACNA1E CYP1B1 CAD GAPDH UGT1A5 DDO ITGA2 UGT1A4 UGT1A3 OXSM HAL | 2.81e-05 | 509 | 107 | 11 | CID000000222 |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; HL60; HG-U133A | 2.84e-05 | 186 | 107 | 7 | 1555_DN | |
| Drug | x Me | 3.01e-05 | 38 | 107 | 4 | CID009600424 | |
| Drug | acacetin | 3.01e-05 | 38 | 107 | 4 | CID005280442 | |
| Drug | 8-azaguanine | 3.35e-05 | 78 | 107 | 5 | CID000008646 | |
| Drug | propranolol glucuronide | 3.54e-05 | 14 | 107 | 3 | CID000119515 | |
| Drug | rimonabant | 3.66e-05 | 265 | 107 | 8 | ctd:C089032 | |
| Drug | latanoprost acid | 3.70e-05 | 40 | 107 | 4 | CID006441636 | |
| Drug | AC1Q6O8B | 4.08e-05 | 41 | 107 | 4 | CID000000334 | |
| Drug | monomethyl phthalate | CYP1B1 NPR2 CAD ADAMTS2 PDGFRB LAMA3 ARID1A CBL ABCB4 PA2G4 MTIF2 HAL DEGS2 MMP17 ALDH7A1 | 4.11e-05 | 957 | 107 | 15 | ctd:C517284 |
| Drug | glutathione reduced | CYP1B1 GAPDH UGT1A5 MMP20 ABCB4 UGT1A4 UGT1A3 MMP11 MMP17 ALDH7A1 OPLAH | 4.34e-05 | 534 | 107 | 11 | CID000000745 |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 4.41e-05 | 15 | 107 | 3 | CID000040469 | |
| Drug | afloqualone | 4.41e-05 | 15 | 107 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 4.41e-05 | 15 | 107 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 4.41e-05 | 15 | 107 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 4.41e-05 | 15 | 107 | 3 | CID000543743 | |
| Drug | PTBP | 4.50e-05 | 42 | 107 | 4 | CID000007393 | |
| Drug | oltipraz | 4.67e-05 | 137 | 107 | 6 | CID000047318 | |
| Drug | N-hydroxy-PhIP | 4.94e-05 | 43 | 107 | 4 | CID000104954 | |
| Drug | UDP-N-acetylglucosamine | 4.96e-05 | 203 | 107 | 7 | CID000001167 | |
| Drug | 7-ethoxycoumarin | 5.37e-05 | 86 | 107 | 5 | CID000035703 | |
| Drug | quercetin-3,4'-diglucoside | 5.40e-05 | 16 | 107 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 5.40e-05 | 16 | 107 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 5.40e-05 | 16 | 107 | 3 | CID005497144 | |
| Drug | sulfinpyrazone | 5.68e-05 | 87 | 107 | 5 | CID000005342 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 6.54e-05 | 17 | 107 | 3 | CID000003573 | |
| Drug | triclocarban | 6.54e-05 | 17 | 107 | 3 | ctd:C009540 | |
| Drug | 6-hydroxychrysene | 6.54e-05 | 17 | 107 | 3 | CID000037766 | |
| Drug | 7-BrMe-12-MeBA | 6.54e-05 | 3 | 107 | 2 | CID000027767 | |
| Drug | cis-diammineplatinum(II | 6.54e-05 | 3 | 107 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.54e-05 | 3 | 107 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 6.54e-05 | 3 | 107 | 2 | CID000127713 | |
| Drug | 2-aminothiophenol | 6.54e-05 | 3 | 107 | 2 | ctd:C005464 | |
| Drug | aminodantrolene | 6.54e-05 | 3 | 107 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 6.54e-05 | 3 | 107 | 2 | CID000093551 | |
| Drug | Nesiritide | 6.54e-05 | 3 | 107 | 2 | DB04899 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.54e-05 | 3 | 107 | 2 | CID005748312 | |
| Drug | 7-methoxymethyl-12-methylbenz(a)anthracene | 6.54e-05 | 3 | 107 | 2 | CID000083361 | |
| Drug | methyl undec-10-enoate | 6.54e-05 | 3 | 107 | 2 | CID000008138 | |
| Drug | peroxynitrite | 6.74e-05 | 373 | 107 | 9 | CID000104806 | |
| Drug | p-nitroanisole | 7.42e-05 | 92 | 107 | 5 | CID000007485 | |
| Drug | 1-hydroxypyrene | 7.65e-05 | 48 | 107 | 4 | CID000021387 | |
| Drug | AC1L3G3T | 7.81e-05 | 93 | 107 | 5 | CID000114866 | |
| Drug | SureCN12722713 | 7.82e-05 | 18 | 107 | 3 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 7.82e-05 | 18 | 107 | 3 | CID000152226 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 7.82e-05 | 18 | 107 | 3 | CID000036614 | |
| Drug | ApApG | 7.82e-05 | 18 | 107 | 3 | CID003081975 | |
| Drug | C1 11-32 | 7.82e-05 | 18 | 107 | 3 | CID000443077 | |
| Drug | C11131 | 7.82e-05 | 18 | 107 | 3 | CID000443076 | |
| Drug | gemfibrozil | 8.70e-05 | 222 | 107 | 7 | CID000003463 | |
| Drug | mepyramine | 8.94e-05 | 154 | 107 | 6 | CID000004992 | |
| Drug | 9-OH-risperidone | 9.26e-05 | 19 | 107 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 9.26e-05 | 19 | 107 | 3 | CID000091433 | |
| Drug | almokalant | 9.26e-05 | 19 | 107 | 3 | CID003033962 | |
| Drug | isoflavone | 9.27e-05 | 155 | 107 | 6 | CID000072304 | |
| Disease | 6-oxopiperidine-2-carboxylate measurement | 4.13e-08 | 3 | 103 | 3 | EFO_0800066 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.28e-06 | 8 | 103 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.42e-06 | 9 | 103 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.42e-06 | 9 | 103 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 4.87e-06 | 10 | 103 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 4.87e-06 | 10 | 103 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.87e-06 | 10 | 103 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 4.87e-06 | 10 | 103 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 6.68e-06 | 11 | 103 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 8.88e-06 | 12 | 103 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 8.88e-06 | 12 | 103 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 1.15e-05 | 13 | 103 | 3 | EFO_0802007 | |
| Disease | serum metabolite measurement | CACNA1E UNC119B WNT3 UGT1A5 ABCA7 ABCB4 UGT1A4 UGT1A3 HAL CSMD1 EXOSC4 PLTP OPLAH | 2.57e-05 | 945 | 103 | 13 | EFO_0005653 |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.71e-05 | 17 | 103 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 3.24e-05 | 18 | 103 | 3 | EFO_0801382 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | tissue factor measurement | 5.25e-05 | 21 | 103 | 3 | EFO_0010623 | |
| Disease | myeloproliferative neoplasm (implicated_via_orthology) | 7.21e-05 | 4 | 103 | 2 | DOID:2226 (implicated_via_orthology) | |
| Disease | colorectal health | 7.66e-05 | 201 | 103 | 6 | EFO_0008460 | |
| Disease | muscular disease (implicated_via_orthology) | 1.20e-04 | 5 | 103 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | xanthurenate measurement | 1.41e-04 | 29 | 103 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.57e-04 | 30 | 103 | 3 | EFO_0600017 | |
| Disease | thyroxine measurement | 2.08e-04 | 83 | 103 | 4 | EFO_0005130 | |
| Disease | hormone measurement | 2.18e-04 | 84 | 103 | 4 | EFO_0004730 | |
| Disease | cholelithiasis | 2.61e-04 | 88 | 103 | 4 | EFO_0004799 | |
| Disease | sunburn | 3.64e-04 | 96 | 103 | 4 | EFO_0003958 | |
| Disease | Liver carcinoma | 4.10e-04 | 507 | 103 | 8 | C2239176 | |
| Disease | apolipoprotein B measurement | 5.32e-04 | 663 | 103 | 9 | EFO_0004615 | |
| Disease | gallstones | 5.68e-04 | 108 | 103 | 4 | EFO_0004210 | |
| Disease | pregnenetriol sulfate measurement | 6.50e-04 | 11 | 103 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.50e-04 | 11 | 103 | 2 | EFO_0600039 | |
| Disease | vitamin D measurement, COVID-19 | 6.77e-04 | 49 | 103 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 8.17e-04 | 119 | 103 | 4 | EFO_0009268, MONDO_0004975 | |
| Disease | pregnenetriol disulfate measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0800587 | |
| Disease | Congenital Hypothyroidism | 9.18e-04 | 13 | 103 | 2 | C0010308 | |
| Disease | coronary artery calcification | 1.03e-03 | 450 | 103 | 7 | EFO_0004723 | |
| Disease | urate measurement, spine bone mineral density | 1.11e-03 | 58 | 103 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | 5-oxoproline measurement | 1.40e-03 | 16 | 103 | 2 | EFO_0010988 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.45e-03 | 139 | 103 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.54e-03 | 65 | 103 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | X-21441 measurement | 1.59e-03 | 17 | 103 | 2 | EFO_0800814 | |
| Disease | histidine measurement | 1.61e-03 | 66 | 103 | 3 | EFO_0009769 | |
| Disease | squamous cell carcinoma | 1.68e-03 | 67 | 103 | 3 | EFO_0000707 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.76e-03 | 68 | 103 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.83e-03 | 69 | 103 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | asthma, response to diisocyanate | 2.26e-03 | 261 | 103 | 5 | EFO_0006995, MONDO_0004979 | |
| Disease | epilepsy (implicated_via_orthology) | 2.60e-03 | 163 | 103 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | triacylglycerol 48:2 measurement | 2.66e-03 | 22 | 103 | 2 | EFO_0010405 | |
| Disease | triacylglycerol 48:3 measurement | 2.66e-03 | 22 | 103 | 2 | EFO_0010406 | |
| Disease | Disease Exacerbation | 2.71e-03 | 165 | 103 | 4 | C0235874 | |
| Disease | Colorectal Carcinoma | 3.23e-03 | 702 | 103 | 8 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NASGEHGIVVFSLGS | 296 | P35503 | |
| HITGAGHASFTIEFD | 271 | Q5SW79 | |
| HFQSDISVAAAGFHL | 1891 | Q96PZ7 | |
| GILATAGTHFNTHVD | 171 | Q15878 | |
| TIALHHGLAVFQDEG | 1146 | P0C0L5 | |
| GLGHDASIAHTETFA | 416 | P49419 | |
| GTADLEGVIDFSAAH | 36 | Q13686 | |
| HTDFLGVDFALTAAG | 321 | A5YM72 | |
| FSVAAAGGLHEFADS | 541 | Q13085 | |
| VFGGKNIHVATAHED | 321 | Q92624 | |
| TAGAVASGFSAKNDH | 121 | P20594 | |
| SGTVAALLAGHHEFF | 211 | Q9ULJ7 | |
| VFGDETHSHFLVIGQ | 156 | Q96PN6 | |
| SSAFVIAHETGHVLG | 391 | Q8WXS8 | |
| SSAFVVAHETGHVLG | 401 | O95450 | |
| VHGAEHGVEDFSVSQ | 2076 | Q8IZY2 | |
| SAGALAAGFQHKDSE | 156 | P17342 | |
| SGVASDTIAFGEHHL | 116 | Q8IUD2 | |
| VAGAFVHFHGVSNLQ | 356 | Q86V24 | |
| LVHAAFVAESAVAGS | 266 | P22695 | |
| VTTAGDAHAAAAALA | 156 | Q7Z444 | |
| DGLQAAFTTAHELGH | 391 | Q9UHI8 | |
| ISGVVLADHSGAFHN | 436 | Q92542 | |
| VAATGGLHEFADSQF | 686 | O00763 | |
| SVAVGHFLGSAELSE | 396 | Q8IW93 | |
| VAAAAAAVFHQQHGG | 161 | O14497 | |
| TGAHAVGDSFRFIAH | 211 | Q9NWU1 | |
| GVHVDGFIANVAHTF | 111 | Q9UQ80 | |
| AAVFSVGFTDAVIHG | 146 | Q8NGM9 | |
| SAGFVDGTALADLSH | 161 | Q9NPD3 | |
| ISGTSFAVGIDFHAE | 1906 | Q9NZR2 | |
| FSEEGGHVVLAHSVL | 3161 | Q16787 | |
| AAVETGGITQHIGAF | 206 | P46199 | |
| SALHIAAFGGHQDIV | 86 | Q7Z6K4 | |
| AVHSGGRHATALTVD | 3051 | O95714 | |
| SHNAIEAIGSATFAG | 96 | Q9BY71 | |
| AAVGAVDFSHLFVTS | 486 | Q13409 | |
| CGATALHFAAEAGHI | 186 | Q9UK73 | |
| HEVVTNHAGFLTIGA | 446 | P55058 | |
| SHQVGVAGAVFDEST | 141 | P53370 | |
| AAFTVAVLAAGISFH | 436 | Q5SWX8 | |
| TAHQELGTAAAAAAA | 86 | O95948 | |
| LVGLGFEEHVQASHF | 316 | O60337 | |
| FTAAGFIHLVENSGD | 236 | A8MYU2 | |
| AGHSVTAEGFSIQDL | 466 | Q6ZVL6 | |
| VAAISTGESTHFVAG | 441 | P17301 | |
| DADGFSALHHAALGG | 46 | Q8WXE0 | |
| VFSAIVFGAVALGHA | 976 | P21439 | |
| FAIANSAEAGDAGVH | 76 | Q99489 | |
| ASGAAEGVSAQSFLH | 16 | Q8NB37 | |
| SSAFVVAHETGHVLG | 391 | O15072 | |
| DGLQSAFTAAHELGH | 351 | O75173 | |
| SGNSADFLLHTVGAE | 921 | Q8N6C5 | |
| DNGGFTSVDDAHFLV | 41 | P42357 | |
| GFAAGIEITNHATAT | 776 | Q86XK2 | |
| TLHEGVRVAAHFGAT | 81 | Q9H840 | |
| LNSFSHVGAGVVHAI | 911 | P12110 | |
| LAIHDISHNAAFGTG | 86 | Q6QHC5 | |
| VATGQVTGFFDAHVE | 236 | Q6IS24 | |
| ESSTFGEGNLAAAHA | 746 | P22681 | |
| GNAAAVGQAAHLSFA | 61 | Q16678 | |
| AAIEATGAVIHFGNG | 226 | Q86Y56 | |
| AAAAHDAGITIFSVG | 486 | O43405 | |
| AAHFADVAGREAGES | 511 | Q92736 | |
| TIALHHGLAVFQDEG | 1146 | P0C0L4 | |
| LGSGAFGQVVEATAH | 606 | P09619 | |
| FGQVVEATAHGLSHS | 611 | P09619 | |
| FTVAAHEFGHALGLA | 221 | O60882 | |
| GTDLLQVAAHEFGHV | 206 | P24347 | |
| VLEVASGSGQHAAHF | 31 | Q96S19 | |
| QGFHHAVAAGATEIS | 156 | Q8TB92 | |
| GVVHSFDGTKEAAAA | 171 | Q6P1N9 | |
| VVFHAVHEFGLTGAS | 776 | Q8TEU7 | |
| DLFAVAVHEFGHAIG | 241 | Q9ULZ9 | |
| NLVVTFDAGGVSGHS | 141 | Q9Y2B2 | |
| FDAGGVSGHSNHIAL | 146 | Q9Y2B2 | |
| TNVGEALAAVHGSEF | 151 | P28069 | |
| AGEFEHVFEASTAGV | 326 | O14841 | |
| HSSTFDAGAGIALND | 291 | P04406 | |
| HDSSAGLEVDVFLGA | 116 | Q6ZRT6 | |
| TLGDAVHNFADGLAV | 501 | Q6P5W5 | |
| VHNFADGLAVGAAFA | 506 | Q6P5W5 | |
| HGATLLHVAAANGFS | 231 | Q96I34 | |
| IVAHGFETHGTARVA | 31 | Q2M3A8 | |
| GGTAQFEAHSDAQAL | 956 | P41252 | |
| HGVAAVLAGTAEAIF | 121 | Q3SY17 | |
| GAHFGESASAHLSDL | 596 | Q6P9B9 | |
| HADSIIGVAFAVGSA | 326 | A4IF30 | |
| TSVFAVASVGHGVFL | 11 | Q92537 | |
| HNFSDGLAIGAAFTE | 606 | Q13433 | |
| DVLFNVAGFVHHGTV | 76 | Q9BUT1 | |
| ASASDVHGNFAFEGI | 451 | Q15036 | |
| AAAAAAEAGLHVSAL | 66 | Q13207 | |
| NSVAHFAGIAREESG | 496 | Q15413 | |
| VGSAARLQAHEAAHA | 676 | Q6ZN55 | |
| HHAADDGVGAAVTEQ | 46 | A6NIH7 | |
| NASGEHGIVVFSLGS | 296 | P35504 | |
| ESAFVHAIASAGVAF | 111 | P56703 | |
| FTHAVSAAGVVNAIS | 116 | Q9H1J7 | |
| HLVASGSEDGSLHVF | 996 | Q9NNW5 | |
| HKEDFASGTAAALAG | 1481 | P27708 | |
| VAGDVFQNGESATHH | 266 | Q9UBW7 | |
| HGVHSSLTAAAAAGA | 476 | Q96F45 | |
| FVHAIASAGVAFAVT | 111 | P56704 | |
| HRLAGHTDTVTGVAF | 791 | A2RRH5 | |
| HTIAAFLGGAAAQEV | 491 | Q13564 | |
| HRVAGAAEVFGNSSE | 16 | Q9NS93 | |
| AHYGAVAAAAAAALH | 311 | Q96T25 | |
| LFDGHHGASAAELTS | 206 | A8MPX8 | |
| NASGEHGIVVFSLGS | 296 | P22310 |